Literature DB >> 26201322

Hepatocyte-mediated cytotoxicity and host defense mechanisms in the alcohol-injured liver.

Benita L McVicker1,2, Geoffrey M Thiele3,4,5, Dean J Tuma3,4, Carol A Casey3,4,6.   

Abstract

The consumption of alcohol is associated with many health issues including alcoholic liver disease (ALD). The natural history of ALD involves the development of steatosis, inflammation (steatohepatitis), fibrosis and cirrhosis. During the stage of steatohepatitis, the combination of inflammation and cellular damage can progress to a severe condition termed alcoholic hepatitis (AH). Unfortunately, the pathogenesis of AH remains uncharacterized. Some modulations have been identified in host defense and liver immunity mechanisms during AH that highlight the role of intrahepatic lymphocyte accumulation and associated inflammatory cytokine responses. Also, it is hypothesized that alcohol-induced injury to liver cells may significantly contribute to the aberrant lymphocytic distribution that is seen in AH. In particular, the regulation of lymphocytes by hepatocytes may be disrupted in the alcoholic liver resulting in altered immunologic homeostasis and perpetuation of disease. In recent studies, it was demonstrated that the direct killing of activated T lymphocytes by hepatocytes is facilitated by the asialoglycoprotein receptor (ASGPR). The ASGPR is a well-characterized glycoprotein receptor that is exclusively expressed by hepatocytes. This hepatic receptor is known for its role in the clearance of desialylated glycoproteins or cells, yet neither its physiological function nor its role in disease states has been determined. Interestingly, alcohol markedly impairs ASGPR function; however, the effect alcohol has on ASGPR-mediated cytotoxicity of lymphocytes remains to be elucidated. This review discusses the contribution of hepatocytes in immunological regulation and, importantly, how pathological effects of ethanol disrupt hepatocellular-mediated defense mechanisms.

Entities:  

Keywords:  Alcoholic hepatitis; Alcoholic liver disease; Asialoglycoprotein receptor; Intrahepatic lymphocytes; Receptor-mediated endocytosis

Year:  2013        PMID: 26201322     DOI: 10.1007/s12072-013-9511-7

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  47 in total

1.  Altered T-lymphocyte responsiveness to polyclonal cell activators is responsible for liver cell necrosis in alcohol-fed rats.

Authors:  Q Cao; R Batey; G Pang; R Clancy
Journal:  Alcohol Clin Exp Res       Date:  1998-05       Impact factor: 3.455

2.  Studies on the liver sequestration of lymphocytes bearing membrane-associated galactose-terminal glycoconjugates: reversal with agents that effectively compete for the asialoglycoprotein receptor.

Authors:  W E Samlowski; G J Spangrude; R A Daynes
Journal:  Cell Immunol       Date:  1984-10-15       Impact factor: 4.868

3.  Hepatocyte cytotoxicity is facilitated by asialoglycoprotein receptor.

Authors:  Clifford S Guy; Sherri L Rankin; Tomasz I Michalak
Journal:  Hepatology       Date:  2011-07-21       Impact factor: 17.425

4.  Hepatic neutrophil infiltration in the pathogenesis of alcohol-induced liver injury.

Authors:  Shashi K Ramaiah; Hartmut Jaeschke
Journal:  Toxicol Mech Methods       Date:  2007       Impact factor: 2.987

Review 5.  Apoptosis in alcoholic and nonalcoholic steatohepatitis.

Authors:  Ariel E Feldstein; Gregory J Gores
Journal:  Front Biosci       Date:  2005-09-01

Review 6.  Targeting hepatocytes for drug and gene delivery: emerging novel approaches and applications.

Authors:  Jian Wu; Michael H Nantz; Mark A Zern
Journal:  Front Biosci       Date:  2002-03-01

7.  Antigen presentation by liver cells controls intrahepatic T cell trapping, whereas bone marrow-derived cells preferentially promote intrahepatic T cell apoptosis.

Authors:  W Z Mehal; F Azzaroli; I N Crispe
Journal:  J Immunol       Date:  2001-07-15       Impact factor: 5.422

8.  Susceptibility to T cell-mediated liver injury is enhanced in asialoglycoprotein receptor-deficient mice.

Authors:  Benita L McVicker; Geoffrey M Thiele; Carol A Casey; Natalia A Osna; Dean J Tuma
Journal:  Int Immunopharmacol       Date:  2013-03-26       Impact factor: 4.932

9.  Immune mechanisms in alcoholic liver disease.

Authors:  Emanuele Albano; Matteo Vidali
Journal:  Genes Nutr       Date:  2009-10-07       Impact factor: 5.523

10.  Ethanol-induced impairments in receptor-mediated endocytosis of asialoorosomucoid in isolated rat hepatocytes: time course of impairments and recovery after ethanol withdrawal.

Authors:  C A Casey; S L Kragskow; M F Sorrell; D J Tuma
Journal:  Alcohol Clin Exp Res       Date:  1989-04       Impact factor: 3.455

View more
  4 in total

1.  Critical roles of conventional dendritic cells in promoting T cell-dependent hepatitis through regulating natural killer T cells.

Authors:  J Wang; X Cao; J Zhao; H Zhao; J Wei; Q Li; X Qi; Z Yang; L Wang; H Zhang; L Bai; Z Wu; L Zhao; Z Hong; Z Yin
Journal:  Clin Exp Immunol       Date:  2017-01-05       Impact factor: 4.330

2.  A Consensus Definitive Classification of Scavenger Receptors and Their Roles in Health and Disease.

Authors:  Mercy R PrabhuDas; Cynthia L Baldwin; Paul L Bollyky; Dawn M E Bowdish; Kurt Drickamer; Maria Febbraio; Joachim Herz; Lester Kobzik; Monty Krieger; John Loike; Benita McVicker; Terry K Means; Soren K Moestrup; Steven R Post; Tatsuya Sawamura; Samuel Silverstein; Robert C Speth; Janice C Telfer; Geoffrey M Thiele; Xiang-Yang Wang; Samuel D Wright; Joseph El Khoury
Journal:  J Immunol       Date:  2017-05-15       Impact factor: 5.422

3.  Visual method for evaluating liver function: targeted in vivo fluorescence imaging of the asialoglycoprotein receptor.

Authors:  Xiaojing Song; Shuyou Wang; Chong Zhao; Weibo Zhang; Guangjun Wang; Shuyong Jia
Journal:  Biomed Opt Express       Date:  2019-09-09       Impact factor: 3.732

Review 4.  Clearance of Apoptotic Cells by Tissue Epithelia: A Putative Role for Hepatocytes in Liver Efferocytosis.

Authors:  Scott P Davies; Gary M Reynolds; Zania Stamataki
Journal:  Front Immunol       Date:  2018-01-25       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.